FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1149273007: Trilaciclib dihydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4554922016 Trilaciclib dihydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4554923014 Trilaciclib dihydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trilaciclib dihydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Trilaciclib (substance) true Inferred relationship Some
Trilaciclib dihydrochloride Is a Pyrrole true Inferred relationship Some
Trilaciclib dihydrochloride Is a Antineoplastic agent (substance) true Inferred relationship Some
Trilaciclib dihydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein kinase inhibitor (disposition) true Inferred relationship Some
Trilaciclib dihydrochloride Is a Protein kinase inhibitor true Inferred relationship Some
Trilaciclib dihydrochloride Is a Enzyme inhibitor false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Trilaciclib dihydrochloride Inferred relationship Some 1
Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trilaciclib dihydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start